1 analysts out of 2 Wall Street brokerage firms rate Ceragon Networks Ltd. (NASDAQ:CRNT) as a Buy, while 0 see it as a Sell. The rest 1 describe it as a Hold. CRNT stock traded higher to an intra-day high of $3.73. At one point in session, its potential discontinued and the price was down to lows at $3.51. Analysts have set CRNT’s consensus price at $4.7, effectively giving it a 32.77% projection on returns. Should the projected estimates be met, then the stock will likely hit its highest price at $5 (up 41.24% from current price levels). CRNT has a 15.9% ROE, higher than the 8.16% average for the industry. The average ROE for the sector is 13.93%.
It is expected that in Mar 2019 quarter CRNT will have an EPS of $0.03, suggesting a -25% growth. For Jun 2019 is projected at $0.06. It means that there could be a 50% growth in the quarter. Yearly earnings are expected to rise by 20% to about $0.24. As for the coming year, growth will be about 8.33%, lifting earnings to $0.26. RSI after the last trading period was 35.92. CRNT recorded a change of -4.84% over the past week and returned -14.29% over the last three months while the CRNT stock’s monthly performance revealed a shift in price of -19.91%. The year to date (YTD) performance stands at -6.35%, and the bi-yearly performance specified an activity trend of 20% while the shares have moved 24.65% for the past 12 months.
Ceragon Networks Ltd. (CRNT) currently trades at $3.54, which is lower by -4.84% its previous price. It has a total of 78.15 million outstanding shares, with an ATR of around 0.23. The company’s stock volume dropped to 1.09 million, worse than 732.12 thousands that represents its 50-day average. A 5-day decrease of about -4.84% in its price means CRNT is now -6.35% lower on year-to-date. The shares had marked a $5.04 52-week high price and the 52 week low of $2.46. Overall, it has seen a growth rate of 24.65 over the last 12 months.
Ceragon Networks Ltd. (NASDAQ:CRNT)’s EPS was $0.06 as reported for the December quarter. In comparison, the same quarter a year ago had an EPS of $0.05. That means that its growth in general now stands at 20%. Therefore, a prediction of $0.05 given by the analysts brought a positive surprise of 20%. CRNT Dec 19 quarter revenue was $85.74 million, compared to $76 million recorded in same quarter last year, giving it a 13% growth rate. The company’s $9.74 million revenue growth that quarter surprised Wall Street and investors will need to consider this as they assess the stock.
Hovnanian Enterprises, Inc. (NYSE:HOV) shares depreciated -2.46% over the last trading period, taking overall 5-day performance up to -6.87%. HOV’s price now at $0.58 is weaker than the 50-day average of $0.68. Getting the trading period increased to 200 days, the stock price was seen at $1.3 on average. The general public currently hold control of a total of 120.36 million shares, which is the number publicly available for trading. The total of shares that it has issued to investors is 139.81 million. The company’s management holds a total of 1%, while institutional investors hold about 35.9% of the remaining shares. HOV share price finished last trade -10.21% below its 20 day simple moving average and its downbeat gap from 200 day simple moving average is -55.56%, while closing the session with -14.4% distance from 50 day simple moving average.
Hovnanian Enterprises, Inc. (HOV) shares were last observed trading -73.15% down the peak of $2.16. Last month’s price growth of -14.07% puts HOV performance for the year now at -15.19%. Consequently, the shares price is trending higher by 1.75%, a 52-week worst price. However, it is losing value with -63.52% in the last 6 months. From a technical perspective, it appears more likely that the stock will experience a Bull Run market as a result of the strong support seen recently between $0.56 and $0.57. The immediate resistance area is now $0.6 Williams’s %R (14) for HOV moved to 100 while the stochastic %K points at 13.95.
HOV’s beta is 1.91; meaning investors could reap higher returns, although it also poses higher risks. The company allocated $0 per share from its yearly profit to its outstanding shares. Its last reported revenue is $380.59 million, which was -9% versus $417.17 million in the corresponding quarter last year. The EPS for Jan 19 quarter came in at $-0.12 compared to $-0.21 in the year-ago quarter and had represented -43% year-over-year earnings per share growth. HOV’s ROA is 1.1%, lower than the 6.96% industry average. Although a more robust percentage would be better, consideration is given to how well peers within the industry performed. Companies within the sector had an ROA of 6.71%.
Analysts estimate full-year growth to be -200%, the target being $-0.03 a share. The upcoming year will see an increase in growth by percentage to 66.67%, more likely to see it hit the $-0.01 per share. The firm’s current profit margin over the past 12 months is 0.9%. HOV ranks lower in comparison to an average of 6.67% for industry peers; while the average for the sector is 13.43%.